Rapport Therapeutics Inc
NASDAQ:RAPP
Rapport Therapeutics Inc
NASDAQ:RAPP
Price:
34.17
USD
-0.15%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
Cash Flow Statement
Cash Flow Statement
Rapport Therapeutics Inc
Rapport Therapeutics Inc
Currency: USD
| Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(69)
|
(87)
|
(78)
|
(80)
|
(88)
|
(98)
|
(111)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
7
|
10
|
10
|
13
|
15
|
16
|
19
|
|
| Other Non-Cash Items |
13
|
14
|
15
|
11
|
14
|
18
|
19
|
|
| Change in Working Capital |
(0)
|
(1)
|
(2)
|
0
|
(3)
|
1
|
4
|
|
| Cash from Operating Activities |
(56)
N/A
|
(73)
-29%
|
(65)
+11%
|
(67)
-3%
|
(76)
-14%
|
(77)
-1%
|
(87)
-13%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(4)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(224)
|
(277)
|
(168)
|
(105)
|
23
|
19
|
(187)
|
|
| Cash from Investing Activities |
(228)
N/A
|
(281)
-23%
|
(170)
+39%
|
(107)
+37%
|
22
N/A
|
19
-16%
|
(187)
N/A
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
223
|
222
|
222
|
158
|
(1)
|
1
|
1
|
|
| Other |
85
|
0
|
0
|
0
|
(0)
|
270
|
269
|
|
| Cash from Financing Activities |
308
N/A
|
307
0%
|
222
-28%
|
158
-29%
|
(1)
N/A
|
270
N/A
|
271
+0%
|
|
| Change in Cash | ||||||||
| Net Change in Cash |
24
N/A
|
(47)
N/A
|
(13)
+72%
|
(17)
-24%
|
(55)
-233%
|
212
N/A
|
(4)
N/A
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(60)
N/A
|
(77)
-28%
|
(67)
+12%
|
(69)
-2%
|
(77)
-12%
|
(78)
-1%
|
(88)
-13%
|
|
Switch to:
Switch to:
See Also
Discover More
